Atlas Trials

Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease

Clinical trial NCT02500784 · WITHDRAWN

Trial details

NCT number
NCT02500784
Sponsor
Palo Alto Veterans Institute for Research
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's DiseaseCognitive Dysfunction
Start date
2023-01-01
Primary completion
2025-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.